Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q3 2025 (September 30)3holders
0new positions
0sold out
1famous investor
$9.99avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($356K), UBS Group AG ($1K) and Bank of America Corp. ($800). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 100 shares sold, net −100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Citadel Advisors | — | Reduce -0.3% | 35,573 | $356K |
| UBS Group AG | — | No change | 143 | $1K |
| Bank of America Corp. | — | No change | 100 | $800 |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.